Ermenegildo Zegna NV
ZGN
Hutchmed (China)
HCM
eBay
EBAY
Enerpac Tool
EPAC
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
NXL Nexalin Technology
- 2.0600
- -0.0300-1.44%
Close Mar 27 16:00 ET
- 1.9900
- -0.0700-3.40%
Post 20:01 ET
27.41MMarket Cap-2.48P/E (TTM)
2.1300High1.9500Low72.01KVolume2.0100Open2.0900Pre Close144.52KTurnover0.67%Turnover RatioLossP/E (Static)13.30MShares4.489952wk High7.46P/B22.25MFloat Cap0.530052wk Low--Dividend TTM10.80MShs Float4.4899Historical High--Div YieldTTM8.61%Amplitude0.2528Historical Low2.0070Avg Price1Lot Size
About Nexalin Technology Company
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices help people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
Company Profile
SymbolNXL
Company NameNexalin Technology
Listing DateSep 16, 2022
Issue Price4.14
Founded2010
CEOMr. Mark White
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address1776 Yorktown,Suite 550
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77056
Phone1-832-260-0222
Websitehttp://www.nexalin.com
Company Executives
- Name
- Position
- Salary
- Mark White
- Director, President, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
- 1.03M
- Dr. David Owens, M.D.
- Chief Medical Officer and Director
- 873.14K
- Carolyn Shelton
- Senior Vice President, Quality, Clinical and Regulatory
- 288.03K
- Leslie Bernhard
- Chairman of the Board
- --
- Alan Kazden
- Independent Director
- --
- Dr. Benjamin V. Hu, M.D.
- Independent Director
- --
- Marilyn Elson
- Controller
- 240.00K